Retirement Systems of Alabama - BIO-TECHNE CORP ownership

BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 567 filers reported holding BIO-TECHNE CORP in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

About BIO-TECHNE CORP

Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.

Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.

In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.

Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.

Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Retirement Systems of Alabama ownership history of BIO-TECHNE CORP
ValueSharesWeighting
Q3 2023$2,423,088
-17.0%
35,597
-0.5%
0.01%
-15.4%
Q2 2023$2,920,803
-15.3%
35,781
-23.0%
0.01%
-13.3%
Q1 2023$3,448,945
-17.2%
46,488
-7.6%
0.02%
-16.7%
Q4 2022$4,167,869
+12.6%
50,288
+285.9%
0.02%
+5.9%
Q3 2022$3,701,000
-17.9%
13,031
+0.2%
0.02%
-10.5%
Q2 2022$4,508,000
-20.0%
13,006
-0.1%
0.02%
-9.5%
Q1 2022$5,637,000
-16.3%
13,017
-0.0%
0.02%
-8.7%
Q4 2021$6,736,000
+4.1%
13,020
-2.5%
0.02%
-4.2%
Q3 2021$6,472,000
-83.4%
13,356
-84.6%
0.02%
-83.0%
Q2 2021$38,933,000
+17.9%
86,468
+0.0%
0.14%
+12.8%
Q1 2021$33,015,000
+20.7%
86,442
+0.4%
0.12%
+15.7%
Q4 2020$27,349,000
+28.2%
86,125
-0.0%
0.11%
+10.2%
Q3 2020$21,337,000
-11.9%
86,129
-6.1%
0.10%
-16.2%
Q2 2020$24,209,000
+39.6%
91,676
+0.3%
0.12%
+21.9%
Q1 2020$17,337,000
-13.6%
91,4280.0%0.10%
+7.9%
Q4 2019$20,069,000
+12.4%
91,428
+0.2%
0.09%
+3.5%
Q3 2019$17,861,000
+16.8%
91,279
+24.4%
0.09%
+21.1%
Q2 2019$15,295,000
+5.1%
73,362
+0.1%
0.07%0.0%
Q1 2019$14,546,000
+105.3%
73,262
+49.6%
0.07%
+82.1%
Q4 2018$7,086,000
-28.8%
48,966
+0.4%
0.04%
-17.0%
Q3 2018$9,952,000
+38.2%
48,760
+0.2%
0.05%
+34.3%
Q2 2018$7,199,000
-1.7%
48,655
+0.4%
0.04%
-2.8%
Q1 2018$7,320,000
-19.0%
48,467
-30.5%
0.04%
-18.2%
Q4 2017$9,035,000
+7.6%
69,741
+0.4%
0.04%0.0%
Q3 2017$8,398,000
+2.9%
69,470
+0.1%
0.04%0.0%
Q2 2017$8,158,000
+15.5%
69,430
-0.1%
0.04%
+12.8%
Q1 2017$7,062,000
-1.2%
69,471
-0.0%
0.04%
-4.9%
Q4 2016$7,145,000
+35.8%
69,480
+44.6%
0.04%
+32.3%
Q3 2016$5,263,000
-2.8%
48,060
+0.1%
0.03%
-3.1%
Q2 2016$5,414,000
+19.4%
48,005
+0.1%
0.03%
+18.5%
Q1 2016$4,533,000
+5.4%
47,956
+0.3%
0.03%
+8.0%
Q4 2015$4,301,000
-1.3%
47,789
+1.4%
0.02%
-3.8%
Q3 2015$4,358,000
-6.1%
47,136
-0.0%
0.03%
+4.0%
Q2 2015$4,643,000
-1.8%
47,156
+0.1%
0.02%0.0%
Q1 2015$4,726,000
+11.6%
47,125
+2.8%
0.02%
+8.7%
Q4 2014$4,235,00045,8350.02%
Other shareholders
BIO-TECHNE CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Broadcrest Asset Management, LLC 300,000$24,489,00021.05%
Montanaro Asset Management Ltd 388,800$31,737,7445.02%
Sandhill Capital Partners LLC 502,447$41,014,7753.74%
Brown Capital Management 3,160,892$258,023,6143.66%
DF DENT & CO INC 3,275,617$267,388,6403.62%
Ownership Capital B.V. 2,282,104$186,288,1503.26%
Jackson Square Partners, LLC 1,361,789$111,162,8363.24%
STONE RUN CAPITAL, LLC 88,135$7,194,4603.20%
Pembroke Management, LTD 339,591$27,720,8132.99%
Summit Creek Advisors LLC 283,693$23,157,8602.90%
View complete list of BIO-TECHNE CORP shareholders